This program is designed to help NIH Phase II awardees transition their SBIR-STTR-developed products into the marketplace by providing companies with individualized assistance toward accomplishing their regulatory and commercialization goals.
Exscien is awarded a Commonwealth of Kentucky SBIR Matching funds grants to assist in the development and the manufacturing set-up for its fusion protein technology.
Claims issued in Patent Application of: Wilson et al. Application No.: 12/866,540; Confirmation No.: 2551 For: TREATMENT OF DISEASE CONDITIONS VIA ADMINISTRATION OF DNA REPAIR ENZYME